GlaxoSmithKline

GlaxoSmithKline

British multinational pharmaceutical, biologics, vaccines and consumer healthcare company.

GlaxoSmithKline (GSK) is in the businesses of pharmaceuticals, vaccines and consumer healthcare. GSK was formerly known as Glaxo Wellcome. The company has centres in the U.S. Belgium, China and the U.K. GSK’s products include treatments for migraines, heart failure and cancer. The company produces vaccines for hepatitis A, hepatitis B and whooping cough. GSK also has dental-care products, over-the-counter medications, nutritional drinks and smoking-cessation products.

GSK’s portfolio includes medicines in respiratory conditions and HIV. Their R&D is focused on the immune system using genetics approaches.

COVID-19

GSK is partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to use their adjuvant platform to improve immune responses to vaccines, including a collaboration with University of Queensland, Australia, which is developing a potential COVID-19 vaccine. GlaxoSmithKline (GSK) is partnering with Clover Biopharmaceuticals to provide its pandemic adjuvant system for preclinical studies with Clover’s Covid-19 S-Trimer since an adjuvant may reduce the amount of vaccine protein required.

Timeline

Products

Product
Launch date
Industry
Website
Fluarix
30 Results
Results per page:
Page 1 of 2

People

Name
Role
LinkedIn

Chris Chau

Employee

Aaron Spivak

Employee

Abbas M. Khambati

Employee

Abdulsalam Muflehi

Employee

Abhijith Vijayendra

Employee

Abigail Villafuerte

Employee

Adam Beveridge

Employee

Adam Briggs Dawson

Employee

Adam Denman

Employee

Aditi Satija

Employee

Aditya Nagrare

Employee

Afolabi Saheed Olabisi

Employee

Ahmed Ashraf Hassan

Employee

Ahmed Jabour

Employee

Ahmed Magdy Moussa

Employee

Aidan Miller

Employee

Ajaipal Singh Chhina

Employee

Ajoy Titus

Employee

Alan Barnard

Employee

Albert Jin

Employee

Aleksander Malinowski

Employee

Alex Tyrrell

Employee

Alexander Colledge

Employee

Alexander Karpenko

Employee

Alexandre Teixeira

Employee

Page 1 of 28
...

Further reading

Title
Author
Link
Type
Date

Our consumer healthcare products | GSK

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Ben Adams
January 22, 2021
FierceBiotech
It's not been a great week for GlaxoSmithKline's partnered R&D projects; after being forced to cull a major lung cancer trial with Merck KGaA, it's now a case of déjà vu as it axes yet another experimental drug study.
Amirah Al Idrus
January 21, 2021
FierceBiotech
GlaxoSmithKline is losing another vaccine executive in the midst of developing a COVID-19 shot. This time, it's Amir Reichman, head of global vaccines engineering core technologies, who will eventually take the helm at BiondVax Pharmaceuticals.
Grace Dean
December 11, 2020
Business Insider
Pharmaceutical giants GlaxoSmithKline and Sanofi said they would improve their formulation and start new COVID-19 vaccine studies in February.
Amirah Al Idrus
November 19, 2020
FierceBiotech
SR One has backed biotech companies for decades as GlaxoSmithKline's venture arm. Now, the firm is striking out on its own, having spun out from the British conglomerate and raised a whopping $500 million fund. The fund, SR One's first, will back "elite" biotechs on both sides of the Atlantic, working on new medicines to address treatment gaps.
Angus Liu
November 19, 2020
FierceBiotech
A small number of cancer patients respond particularly well to drugs. A comprehensive genomic analysis of these so-called "exceptional responders" is now helping National Cancer Institute scientists identify molecular changes that could potentially be leveraged to develop new oncology therapies.
Alex Keown
November 6, 2020
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Amirah Al Idrus
July 14, 2020
FierceBiotech
Last week, FDA staffers laid out their concerns about eye-related side effects that can come with GlaxoSmithKline's anti-BCMA cancer treatment. Despite questions about whether those issues--which include vision loss so severe patients gave up reading or driving--could be identified and managed effectively, the drug emerged from an advisory committee meeting with a 12-0 vote in favor of approval.
Sara Gilgore
June 30, 2020
AmericanInno
These are the people, companies, initiatives and organizations innovating across the ecosystem.
Ben Adams
July 7, 2020
FierceBiotech
Hoping to broaden shots on target, GlaxoSmithKline is continuing its strategy of giving out access to its vaccine platform as it adds Medicago to its growing partners list.
Ben Adams
June 16, 2020
FierceBiotech
As GlaxoSmithKline looks to deepen its cancer R&D, it's penned an oncology development program with Ideaya Biosciences.
Alex Keown
May 29, 2020
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Alex Keown
May 8, 2020
BioSpace
Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
May 6, 2020
clinicaltrials.gov
Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease - Full Text View.
Bloomberg
April 29, 2020
@bsindia
The firm may offload part or all of its 5.7% holding in HUL through a series of block trades
Agencies
April 14, 2020
@bsindia
The drugmakers said they expect to start clinical trials for the vaccine in the second half of this year.
Reuters Editorial
April 3, 2020
IN
GlaxoSmithKline plc said on Friday its treatment for a chronic inflammatory disease of the nasal passage linings or sinuses met the main goals in a late-stage study.
Zoe Schiffer
March 27, 2020
The Verge
The message is spreading through text messages and over Twitter, and it claims to be coming from a Vienna laboratory studying COVID-19. It has all of the classic signs of misinformation.
Clarrie Feinstein
September 20, 2019
Business Insider
Emma Walmsley took over as CEO of pharmaceutical giant GlaxoSmithKline in 2017.
Donald G. McNeil Jr.
June 24, 2019
www.nytimes.com
The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.
JAMIE CONDLIFFE
December 19, 2018
www.nytimes.com
The new venture will own an array of popular pain relievers, toothpastes, cold treatments, vitamins and dietary supplements.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.